Ignite Creation Date:
2024-05-06 @ 6:11 PM
Last Modification Date:
2024-10-26 @ 2:43 PM
Study NCT ID:
NCT05570448
Status:
RECRUITING
Last Update Posted:
2022-10-06
First Post:
2022-09-29
Brief Title:
Anti-Reflux Endoscopic TX Using APC AREA in GERD Patients The AREA Study
Sponsor:
Midwest Veterans Biomedical Research Foundation
Organization:
Midwest Veterans Biomedical Research Foundation
Study Overview
Official Title:
Anti-Reflux Endoscopic Therapy Using Argon Plasma Coagulation AREA in Gastroesophageal Reflux Disease GERD Patients A Single Center Randomized Sham Controlled Trial The AREA Study
Status:
RECRUITING
Status Verified Date:
2022-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AREA21
Brief Summary:
This will be a randomized clinical trial examining the efficacy and safety of ARAT intervention group in patients with chronic GERD symptoms typical symptoms of GERD ie heartburn or acid refluxregurgitation at least twice a week for the last 6 months
Patients must have a positive pH test and a negative manometry no treatment procedure
Patients must have a positive pH test and a negative manometry no treatment procedure
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 1650419 | OTHER | IRBnet | None |